{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:00:21Z","timestamp":1790704821449,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12888-017-1232-3","type":"journal-article","created":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T02:07:14Z","timestamp":1488247634000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Influence of socioeconomic status on antipsychotic prescriptions among youth in France"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0005-4765","authenticated-orcid":false,"given":"Olivier","family":"Bonnot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Dufresne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Michaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Pivette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anicet","family":"Chaslerie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Sauvaget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Vigneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,28]]},"reference":[{"key":"1232_CR1","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jaac.2013.02.008","volume":"52","author":"J McClellan","year":"2013","unstructured":"McClellan J, Stock S, American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI). Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry. 2013;52:976\u201390.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1232_CR2","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.chc.2012.07.004","volume":"21","author":"BI Goldstein","year":"2012","unstructured":"Goldstein BI, Sassi R, Diler RS. Pharmacologic treatment of bipolar disorder in children and adolescents. Child Adolesc Psychiatr Clin N Am. 2012;21:911\u201339.","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"1232_CR3","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.2174\/1381612821666150619092903","volume":"21","author":"L Carton","year":"2015","unstructured":"Carton L, Cottencin O, Lapeyre-Mestre M, Geoffroy PA, Favre J, Simon N, et al. Off-Label prescribing of antipsychotics in adults, children and elderly individuals: A systematic review of recent prescription trends. Curr Pharm Des. 2015;21:3280\u201397.","journal-title":"Curr Pharm Des"},{"key":"1232_CR4","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1001\/jamapsychiatry.2015.0500","volume":"72","author":"M Olfson","year":"2015","unstructured":"Olfson M, King M, Schoenbaum M. Treatment of young people with antipsychotic medications in the United States. JAMA Psychiatry. 2015;72:867\u201374.","journal-title":"JAMA Psychiatry"},{"key":"1232_CR5","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jaac.2014.08.009","volume":"53","author":"C Arango","year":"2014","unstructured":"Arango C, Gir\u00e1ldez M, Merch\u00e1n-Naranjo J, Baeza I, Castro-Fornieles J, Alda JA, et al. Second-generation antipsychotic use in children and adolescents: a 6-month prospective cohort study in drug-naive patients. J Am Acad Child Adolesc Psychiatry. 2014;53:1179\u201390,1190.e1.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1232_CR6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/JCP.0b013e3182549259","volume":"32","author":"D Cohen","year":"2012","unstructured":"Cohen D, Bonnot O, Bodeau N, Consoli A, Laurent C. Adverse effects of second-generation antipsychotics in children and adolescents: a Bayesian meta-analysis. J Clin Psychopharmacol. 2012;32:309\u201316.","journal-title":"J Clin Psychopharmacol"},{"key":"1232_CR7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/pds.2082","volume":"20","author":"GC Alexander","year":"2011","unstructured":"Alexander GC, Gallagher SA, Mascola A, Moloney RM, Stafford RS. Increasing off-label use of antipsychotic medications in the United States, 1995\u20132008. Pharmacoepidemiol Drug Saf. 2011;20:177\u201384.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1232_CR8","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1177\/070674371205701201","volume":"57","author":"M Olfson","year":"2012","unstructured":"Olfson M. Epidemiologic and clinical perspectives on antipsychotic treatment of children and adolescents. Can J Psychiatry Rev Canadienne Psychiatrie. 2012;57:715\u20136.","journal-title":"Can J Psychiatry Rev Canadienne Psychiatrie"},{"key":"1232_CR9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1600-0447.2009.01425.x","volume":"121","author":"H Verdoux","year":"2010","unstructured":"Verdoux H, Tournier M, B\u00e9gaud B. Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies. Acta Psychiatr Scand. 2010;121:4\u201310.","journal-title":"Acta Psychiatr Scand"},{"key":"1232_CR10","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/archgenpsychiatry.2012.647","volume":"69","author":"M Olfson","year":"2012","unstructured":"Olfson M, Blanco C, Liu SM, Wang S, Correll CU. National trends in the office-based treatment of children, adolescents, and adults with antipsychotics. Arch Gen Psychiatry. 2012;69:1247\u201356.","journal-title":"Arch Gen Psychiatry"},{"key":"1232_CR11","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s00127-013-0702-2","volume":"48","author":"YC Hsu","year":"2013","unstructured":"Hsu YC, Chien IC, Tan HK, Lin CH, Cheng SW, Chou YJ, et al. Trends, correlates, and disease patterns of antipsychotic use among children and adolescents in Taiwan. Soc Psych Psych Epid. 2013;48:1889\u201396.","journal-title":"Soc Psych Psych Epid"},{"key":"1232_CR12","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/070674371205700109","volume":"57","author":"S Alessi-Severini","year":"2012","unstructured":"Alessi-Severini S, Biscontri RG, Collins DM, Sareen J, Enns MW. Ten years of antipsychotic prescribing to children: a Canadian population-based study. Can J Psychiat. 2012;57:52\u20138.","journal-title":"Can J Psychiat"},{"key":"1232_CR13","volume":"4","author":"L Marston","year":"2014","unstructured":"Marston L, Nazareth I, Petersen I, Walters K, Osborn DP. Prescribing of antipsychotics in UK primary care: a cohort study. BMJ Open. 2014;4, e006135.","journal-title":"BMJ Open"},{"key":"1232_CR14","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00787-014-0668-y","volume":"24","author":"H Verdoux","year":"2015","unstructured":"Verdoux H, Pambrun E, Cortaredona S, Tournier M, Verger P. Antipsychotic prescribing in youths: a French community-based study from 2006 to 2013. Eur Child Adoles Psy. 2015;24:1181\u201391.","journal-title":"Eur Child Adoles Psy"},{"key":"1232_CR15","unstructured":"INSEE, R\u00e9partition des m\u00e9decins et chirurgiens. 2016. https:\/\/www.insee.fr\/fr\/statistiques\/2012677 . Accessed 13 Feb 2017."},{"key":"1232_CR16","unstructured":"ATC Classification 2015. http:\/\/www.whocc.no\/atc_ddd_index\/ . Accessed 13 Feb 2017."},{"key":"1232_CR17","unstructured":"IDRES, LEs b\u00e9n\u00e9ficiaires de la CMU-C. 2015. http:\/\/www.irdes.fr\/EspaceEnseignement\/ChiffresGraphiques\/Cadrage\/CMU\/CMUC.htm . Accessed 13 Feb 2017."},{"key":"1232_CR18","unstructured":"CNOM, D\u00e9mographie m\u00e9dicale. 2015. http:\/\/www.conseilnational.medecin.fr\/sites\/default\/files\/pays_de_la_loire_2013_0.pdf . Accessed 13 Feb 2017."},{"key":"1232_CR19","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1471-244X-9-72","volume":"9","author":"E Acquaviva","year":"2009","unstructured":"Acquaviva E, Legleye S, Auleley GR, Deligne J, Carel D, Falissard BB. Psychotropic medication in the French child and adolescent population: prevalence estimation from health insurance data and national self-report survey data. BMC Psychiatry. 2009;9:72.","journal-title":"BMC Psychiatry"},{"key":"1232_CR20","unstructured":"Observatoire Fran\u00e7ais des Drogues et Toxicomanies. Estimation 2014 des consommations de produits psychoactifs \u00e0 17 ans. 2016. http:\/\/www.ofdt.fr\/BDD\/publications\/docs\/eisxfbv4b.pdf . Accessed 13 Feb 2017."},{"key":"1232_CR21","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1089\/cap.2014.0058","volume":"25","author":"V Kovess","year":"2015","unstructured":"Kovess V, Choppin S, Gao F, Pivette M, Husky M, Leray E. Psychotropic medication use in French children and adolescents. J Child Adolesc Psychopharmacol. 2015;25:168\u201375.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"1232_CR22","first-page":"25","volume":"111","author":"CJ Bachmann","year":"2014","unstructured":"Bachmann CJ, Lempp T, Glaeske G, Hoffmann F. Antipsychotic prescription in children and adolescents: an analysis of data from a German statutory health insurance company from 2005 to 2012. Deutsches Arzteblatt International. 2014;111:25\u201334.","journal-title":"Deutsches Arzteblatt International"},{"key":"1232_CR23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2431-11-40","volume":"11","author":"A Clavenna","year":"2011","unstructured":"Clavenna A, Andretta M, Pilati P, Dusi M, Gangemi M, Gattoni MB, et al. Antidepressant and antipsychotic use in an Italian pediatric population. BMC Pediatr. 2011;11:40.","journal-title":"BMC Pediatr"},{"key":"1232_CR24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1753-2000-2-26","volume":"2","author":"JM Zito","year":"2008","unstructured":"Zito JM, Safer DJ, de Jong-van den Berg LT, Janhsen K, Fegert JM, Gardner JF, et al. A three-country comparison of psychotropic medication prevalence in youth. Child Adolesc Psychiatry Ment Health. 2008;2:26.","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"1232_CR25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1440-1614.2001.00902.x","volume":"35","author":"DM Fergusson","year":"2001","unstructured":"Fergusson DM, Horwood LJ, The Christchurch Health and Development Study. The Christchurch Health and Development Study: Review of findings on child and adolescent mental health. Aust NZ J Psychiatry. 2001;35:287\u201396.","journal-title":"Aust NZ J Psychiatry"},{"key":"1232_CR26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.31887\/DCNS.2009.11.1\/krmerikangas","volume":"11","author":"KR Merikangas","year":"2009","unstructured":"Merikangas KR, Nakamura EF, Kessler RC. Epidemiology of mental disorders in children and adolescents. Dial Clin Neurosci. 2009;11:7\u201320.","journal-title":"Dial Clin Neurosci"},{"key":"1232_CR27","doi-asserted-by":"crossref","unstructured":"Qi CH, et al. The performance of low-income, African American children on the Preschool Language Scale-3. J Speech Lang Hear Res. 2003;46(3):576\u201390.","DOI":"10.1044\/1092-4388(2003\/046)"},{"key":"1232_CR28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1744-6171.2008.00166.x","volume":"22","author":"C Dashiff","year":"2009","unstructured":"Dashiff C, DiMicco W, Myers B, Sheppard K. Poverty and adolescent mental health. J Child Adolesc Psychiatr Nurs. 2009;22:23\u201332.","journal-title":"J Child Adolesc Psychiatr Nurs"},{"key":"1232_CR29","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/mp.2012.23","volume":"17","author":"JL Rapoport","year":"2012","unstructured":"Rapoport JL, Giedd JN, Gogtay N. Neurodevelopmental model of schizophrenia: update 2012. Mol Psychiatry. 2012;17:1228\u201338.","journal-title":"Mol Psychiatry"},{"key":"1232_CR30","unstructured":"Score Sante. Eco-Donn\u00e9es Sant\u00e9. 2016. http:\/\/www.scoresante.org\/score2008\/sindicateurs.html . Accessed 13 Feb 2017."},{"key":"1232_CR31","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/070674371205701202","volume":"57","author":"SB Patten","year":"2012","unstructured":"Patten SB, Waheed W, Bresee L. A review of pharmacoepidemiologic studies of antipsychotic use in children and adolescents. Can J Psychiat. 2012;57:717\u201321.","journal-title":"Can J Psychiat"},{"key":"1232_CR32","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jaac.2014.08.009","volume":"53","author":"C Arango","year":"2014","unstructured":"Arango C, Gir\u00e1ldez M, Merch\u00e1n-Naranjo J, Baeza I, Castro-Fornieles J, Alda JA, et al. Second-generation antipsychotic use in children and adolescents: a 6-month prospective cohort study in drug-na\u00efve patients. J Am Acad Child Adolesc Psychiatry. 2014;53:1179\u201390,1190.e1. doi: 10.1016\/j.jaac.2014.08.009 .","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"Suppl 1","key":"1232_CR33","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/j.encep.2010.08.009","volume":"37","author":"FJ Bayl\u00e9","year":"2011","unstructured":"Bayl\u00e9 FJ, Blanc O, De Chazeron I, Lesturgeon J, Lan\u00e7on C, Caci H, et al. Pharmacological management of anxiety in patients suffering from schizophrenia. Enc\u00e9phale. 2011;37 Suppl 1:S83\u20139.","journal-title":"Enc\u00e9phale"},{"key":"1232_CR34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1527-3458.2004.tb00023.x","volume":"10","author":"M Bourin","year":"2004","unstructured":"Bourin M, Dailly E, Hasc\u00f6et M. Preclinical and clinical pharmacology of cyamemazine: anxiolytic effects and prevention of alcohol and benzodiazepine withdrawal syndrome. CNS Drug Rev. 2004;10:219\u201329.","journal-title":"CNS Drug Rev"},{"key":"1232_CR35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.psychres.2012.01.009","volume":"198","author":"A Benyamina","year":"2012","unstructured":"Benyamina A, Naassila M, Bourin M. Potential role of cortical 5-HT (2A) receptors in the anxiolytic action of cyamemazine in benzodiazepine withdrawal. Psychiatry Res. 2012;198:307\u201312.","journal-title":"Psychiatry Res"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-017-1232-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T22:18:59Z","timestamp":1658701139000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-017-1232-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,28]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1232"],"URL":"https:\/\/doi.org\/10.1186\/s12888-017-1232-3","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,28]]},"article-number":"82"}}